ATE73347T1 - Antivirales immunotherapeutisches mittel und dessen herstellung. - Google Patents
Antivirales immunotherapeutisches mittel und dessen herstellung.Info
- Publication number
- ATE73347T1 ATE73347T1 AT86906571T AT86906571T ATE73347T1 AT E73347 T1 ATE73347 T1 AT E73347T1 AT 86906571 T AT86906571 T AT 86906571T AT 86906571 T AT86906571 T AT 86906571T AT E73347 T1 ATE73347 T1 AT E73347T1
- Authority
- AT
- Austria
- Prior art keywords
- immunotherapeutic agent
- production
- man
- present
- antiviral immunotherapeutic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/785,070 US4744984A (en) | 1985-10-08 | 1985-10-08 | Antiviral immunotherapeutic agent and preparation thereof |
EP86906571A EP0238657B1 (de) | 1985-10-08 | 1986-10-08 | Antivirales immunotherapeutisches mittel und dessen herstellung |
PCT/US1986/002118 WO1987002249A1 (en) | 1985-10-08 | 1986-10-08 | Antiviral immunotherapeutic agent and preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE73347T1 true ATE73347T1 (de) | 1992-03-15 |
Family
ID=25134365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT86906571T ATE73347T1 (de) | 1985-10-08 | 1986-10-08 | Antivirales immunotherapeutisches mittel und dessen herstellung. |
Country Status (8)
Country | Link |
---|---|
US (1) | US4744984A (de) |
EP (1) | EP0238657B1 (de) |
AT (1) | ATE73347T1 (de) |
AU (1) | AU605116B2 (de) |
CA (1) | CA1293190C (de) |
DE (1) | DE3684305D1 (de) |
NO (1) | NO874364D0 (de) |
WO (1) | WO1987002249A1 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2092183C1 (ru) * | 1988-05-26 | 1997-10-10 | Ника Хелт Продактс Лимитед (Лихтенштейн) | Антивирусный или антибактериальный состав и способ его употребления |
PL173978B1 (pl) * | 1992-07-13 | 1998-05-29 | Nika Health Products Ltd | Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej |
BR9406496A (pt) * | 1993-01-29 | 1996-01-02 | Vetrepharm Inc | Processo e composição para estimulação do sistema imunológico em um ser humano ou animal |
AU7488794A (en) * | 1993-08-27 | 1995-03-21 | Vetrepharm, Inc. | Composition and method for stimulation of reproductive performance |
AU726330B2 (en) * | 1993-08-27 | 2000-11-02 | Vetrepharm, Inc. | Composition and method for stimulation of reproductive performance |
RU2040932C1 (ru) * | 1993-12-17 | 1995-08-09 | Крестьянское хозяйство "Агрофирма Дижа" | Препарат, влияющий на тканевой обмен и применение штамма гриба fusarium sambucinum fuckel var ossicolum (berk.et curf) bilai для его получения |
DE4422859C2 (de) * | 1994-06-30 | 2000-10-05 | Laves Arzneimittel Gmbh | Wäßrige Zellextrakte aus Mykobacterien |
US6303295B1 (en) * | 1995-07-14 | 2001-10-16 | University Of Georgia Research Foundation, Inc. | Selenoproteins, coding sequences and methods |
AUPO359396A0 (en) | 1996-11-13 | 1996-12-05 | Amrad Operations Pty. Limited | A method of treatment and pharmaceutical compositions useful for same |
CN1153574C (zh) * | 1997-04-02 | 2004-06-16 | 比奥尼斯生命科学公司 | 细菌细胞壁提取物在制备预防,治疗或排除原生动物或寄生虫疾病的药物组合物上的应用 |
JP4335435B2 (ja) | 1997-08-05 | 2009-09-30 | バイオニケ ライフ サイエンシーズ インコーポレイテッド | 細胞増殖および細胞死を調節する組成物および方法 |
US6890541B1 (en) | 1999-07-23 | 2005-05-10 | Bioniche Life Sciences, Inc. | Method for enhancing production performance in an animal |
CA2393808A1 (en) * | 1999-12-13 | 2001-06-21 | Bioniche Life Sciences Inc. | Anti-cancer synthetic oligonucleotides |
DK1250152T3 (da) * | 1999-12-28 | 2013-08-26 | Bioniche Urology Ip Inc | Synergistisk sammensætning indeholdende hyaluronsyre til behandling af cancer |
JP2004516333A (ja) | 2001-01-04 | 2004-06-03 | ユニバーシティー オブ サスカチェワン | 腸管出血性大腸菌ワクチン |
WO2003009859A1 (fr) * | 2001-07-19 | 2003-02-06 | Azuma, Ichiro | Immunotherapie pour humains |
CN1296059C (zh) * | 2003-04-04 | 2007-01-24 | 张素琴 | 草分支杆菌免疫液 |
WO2005042746A1 (en) | 2003-10-31 | 2005-05-12 | The University Of British Columbia | Bacterial virulence factors and uses thereof |
ES2231037B1 (es) * | 2003-10-31 | 2005-12-16 | Archivel Technologies, Sl | Agente inmunoterapico util para el tratamiento combinado de la tuberculosis en asociacion con otros farmacos. |
SI2162149T1 (sl) | 2007-06-01 | 2014-04-30 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Cepivo za preprečevanje relapsa raka na dojki |
BRPI0922849B1 (pt) | 2008-12-10 | 2023-01-24 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc | Composição de vacina com uma quantidade eficaz de um peptídeo gp2 e de gm-csf |
WO2011020094A1 (en) * | 2009-08-14 | 2011-02-17 | The Board Of Regents Of The University Of Texas System | Use of synthetic single-stranded rna (ssrna) as a therapeutic agent to activate nod2-dependent immune response against viral infection |
US9044422B2 (en) | 2010-10-13 | 2015-06-02 | Bioniche Urology Ip Inc. | Bacterial ribonucleic acid cell wall compositions and methods of making and using them |
ITTO20120346A1 (it) | 2012-04-18 | 2013-10-19 | Turmond S P A | Coltello multiplo rotante per il taglio longitudinale di nastri |
US9962436B2 (en) | 2012-07-26 | 2018-05-08 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Multimeric fusion protein vaccine and immunotherapeutic |
EP2777711A1 (de) | 2013-03-11 | 2014-09-17 | Icon Genetics GmbH | HER2/neu-Krebsimpfstoff |
US9579370B2 (en) | 2014-03-04 | 2017-02-28 | The Board Of Regents Of The University Of Texas System | Compositions and methods for enterohemorrhagic Escherichia coli (EHEC)vaccination |
US10226520B2 (en) | 2014-03-04 | 2019-03-12 | The Board Of Regents Of The University Of Texa System | Compositions and methods for enterohemorrhagic Escherichia coli (EHEC) vaccination |
US11788631B2 (en) * | 2020-02-28 | 2023-10-17 | Columbia Insurance Company | Barrel valve |
WO2021185851A1 (en) | 2020-03-17 | 2021-09-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Vaccine compositions for hiv prevention and treatment |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3172815A (en) * | 1962-04-24 | 1965-03-09 | Warner Lambert Pharmaceutical | Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof |
US3529057A (en) * | 1964-08-14 | 1970-09-15 | Takeda Chemical Industries Ltd | Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections |
US3331741A (en) * | 1964-12-03 | 1967-07-18 | Warner Lambert Pharmaceutical | Process for the preparation of a soluble bacterial extract |
FR2184531B1 (de) * | 1972-05-19 | 1975-10-17 | Anvar | |
US4069314A (en) * | 1973-02-23 | 1978-01-17 | Christopher Adlam | Glycopeptide extract |
US4340586A (en) * | 1977-02-18 | 1982-07-20 | Adam Bekierkunst | Pharmaceutical preparation for treating disorders of the skin |
US4520019A (en) * | 1982-04-29 | 1985-05-28 | Ribi Immunochem Research, Inc. | Stable composition and preparation thereof |
US4505903A (en) * | 1982-06-30 | 1985-03-19 | Ribi Immunochem Research, Inc. | Pyridine soluble extract of a microorganism |
US4504473A (en) * | 1982-06-30 | 1985-03-12 | Ribi Immunochem Research, Inc. | Pyridine soluble extract of a microorganism |
US4503048A (en) * | 1982-06-30 | 1985-03-05 | Ribi Immunochem Research, Inc. | Pyridine soluble extract of a microorganism |
-
1985
- 1985-10-08 US US06/785,070 patent/US4744984A/en not_active Expired - Lifetime
-
1986
- 1986-10-08 DE DE8686906571T patent/DE3684305D1/de not_active Expired - Lifetime
- 1986-10-08 EP EP86906571A patent/EP0238657B1/de not_active Expired - Lifetime
- 1986-10-08 AT AT86906571T patent/ATE73347T1/de not_active IP Right Cessation
- 1986-10-08 WO PCT/US1986/002118 patent/WO1987002249A1/en active IP Right Grant
- 1986-10-08 AU AU65258/86A patent/AU605116B2/en not_active Expired
- 1986-10-08 CA CA000520049A patent/CA1293190C/en not_active Expired - Lifetime
-
1987
- 1987-10-20 NO NO874364A patent/NO874364D0/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP0238657A1 (de) | 1987-09-30 |
AU605116B2 (en) | 1991-01-10 |
WO1987002249A1 (en) | 1987-04-23 |
EP0238657B1 (de) | 1992-03-11 |
DE3684305D1 (de) | 1992-04-16 |
NO874364D0 (no) | 1987-10-20 |
EP0238657A4 (de) | 1988-05-31 |
CA1293190C (en) | 1991-12-17 |
AU6525886A (en) | 1987-05-05 |
US4744984A (en) | 1988-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE73347T1 (de) | Antivirales immunotherapeutisches mittel und dessen herstellung. | |
EP0199479A3 (en) | Ozone decontamination of blood and blood products | |
DE3684363D1 (de) | Phosphonylmethoxyalkyl-adeninen zur behandlung von viruskrankheiten. | |
MY101842A (en) | Treatment of oral diseases. | |
DE3750934T2 (de) | Behandlung von nicht-Akne-entzündlichen und -infektiösen Hautkrankheiten. | |
DE69418183T2 (de) | Immunotherapeutische zubereitung | |
GR3005768T3 (de) | ||
JPS54110310A (en) | Inactivating agent of virus within human or animal body and production thereof | |
FI880961A0 (fi) | Synergistisk effekt av lymfokiner och dubbelstraengade rna-sekvenser. | |
ATE135914T1 (de) | Aica riboside zur prophylaktischen behandlung von krankheiten mit einer verminderten durchblutung. | |
PT600396E (pt) | Vacinas contra protozoarios intestinais | |
DE69127713T2 (de) | Behandlung von Abgasen, die Silikon- und/oder Phosphorverbindungen enthalten | |
DE69004451D1 (de) | Prophylaxe und Behandlung von Herpesvirus-Infektionen. | |
DE69429521D1 (de) | Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung | |
ATE30114T1 (de) | Mittel zur pflege oder behandlung der menschlichen haut. | |
DE3775278D1 (de) | Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen. | |
ATE26267T1 (de) | Pyrimidin-derivate, ausgestattet mit antiviraler wirkung. | |
FR2593703B1 (fr) | Application du butyl-4-diphenyl-1,2-pyrazolidine-dione-3,5 comme agent antiviral chez l'homme ou l'animal | |
ATE153533T1 (de) | Zubereitungen, die acyclovir-ähnliche verbindungen und 2'-vinylsubstituierte nukleosidanaloge enthalten, zur behandlung viraler infektionen | |
DE3883754D1 (de) | Mittel zur prophylaxe und behandlung von viralen infektionskrankheiten. | |
IT7828549A0 (it) | Composizione terapeutica per il trattamento di infezioni e malattie di animali da allevamento. | |
FR2088229A1 (en) | Medicaments contg cellular rna - formation of interferon and treatment of viral infections | |
NL178014B (nl) | Werkwijze voor het behandelen van virusstammen alsmede werkwijze voor het bereiden van preparaten voor de profylaxe en behandeling van virale en bacteriele infecties bij mens en dier op basis van dergelijke behandelde virusstammen. | |
GB8629432D0 (en) | Treating skin virus infections | |
DE343258T1 (de) | Mittel zur prophylaxe und behandlung von viralen infektionskrankheiten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EELA | Cancelled due to lapse of time |